Billionaire Bargain Bin: 3 Stocks the Forbes 400 Loves (That You've Never Heard Of)InvestorPlace • 04/09/24
The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your PortfolioInvestorPlace • 03/27/24
Royalty Pharma (RPRX) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/16/24
Wall Street Thinks These 3 Stocks Are Hidden Gems That Could Soar 43% to 59% Over the Next 12 MonthsThe Motley Fool • 02/16/24
Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024GlobeNewsWire • 01/30/24
Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx ConferenceGlobeNewsWire • 11/27/23
MedinCell Applauds Teva and Royalty Pharma Collaboration to Further Accelerate Olanzapine LAI Program (Codename: mdc-TJK or TEV-‘749)Business Wire • 11/13/23
Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai ProgramGlobeNewsWire • 11/13/23
Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI ProgramBusiness Wire • 11/13/23
Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on EvrysdiGlobeNewsWire • 10/19/23